Close

Meridian Bioscience (VIVO) Reports In-Line Q1 EPS

January 27, 2016 7:34 AM EST

Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $48.6 million.

For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings